Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
4.025
+0.255 (6.76%)
Dec 26, 2024, 3:52 PM EST - Market open
Metagenomi Employees
Metagenomi had 236 employees as of December 31, 2023.
Employees
236
Change
n/a
Growth
n/a
Revenue / Employee
$233,390
Profits / Employee
-$313,364
Market Cap
150.63M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 236 | - | - |
Related Stocks
Company Name | Employees |
---|---|
The Joint | 794 |
Adaptimmune Therapeutics | 449 |
Sutro Biopharma | 302 |
Pro-Dex | 148 |
EUDA Health Holdings | 106 |
Biomea Fusion | 103 |
Nanobiotix | 102 |
InflaRx | 62 |
MGX News
- 14 days ago - Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV” - GlobeNewsWire
- 16 days ago - Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - GlobeNewsWire
- 4 weeks ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 4 weeks ago - FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi - Business Wire
- 4 weeks ago - The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Metagenomi Inc - Accesswire
- 4 weeks ago - MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 4 weeks ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Assist The Schall Law Firm - Accesswire
- 4 weeks ago - MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit - PRNewsWire